Category: Cardiac Assist DevicesSyndicate content

Recalls: Cardiac Science pulls AEDs and Flight Medical recalls ventilator cables

March 1, 2012 by MassDevice staff

Cardiac Science recalls a suite of automated external defibrillators over defective circuit boards and Flight Medical pulls ventilator cables that may cause electrical shortages.

Cardiac Science logo

Cardiac Science's voluntary field correction for a suite of automated external defibrillators got Class I recall status from the FDA over concerns that a failed component may keep the device from providing life-saving therapy during a heart attack.

The company's PowerHeart G3 AEDs are mobile devices, often found in hospitals, schools or physicians' offices, intended to be used by trained personnel to deliver defibrillation therapy to someone suffering sudden cardiac arrest.

Study: Stents no better than pills for some heart patients | MassDevice.com On Call

February 28, 2012 by MassDevice staff

New research suggests that stable heart patients with stents are no better off than patients given less costly drug regimens.

Updated: March 15, 2012 9:30 a.m.

MassDevice On Call

MASSDEVICE ON CALL — Stable heart disease patients were no better off with a stent with less-costly drug therapy in a recent study comparing the 2 treatments. *

Implanting a stent to prop open blocked arteries represents a more costly alternative that failed to improve outcomes in stable patients, according to researchers from the Stony Brook University Medical Center in New York.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

UPDATE: World Heart CFO on layoffs, future plans

February 24, 2012 by MassDevice staff

World Heart Corp. is pushing ahead with its MiFlow heart pump despite laying off some 77% of its remaining workforce, CFO Morgan Brown tells MassDevice.com.

World Heart Corp.

A skeleton crew of 6 employees at World Heart Corp. (NSDQ:WHRT) will push ahead with the development of its MiFlow heart pump despite layoffs for 77% of their colleagues, CFO Morgan Brown told MassDevice.com this morning.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

World Heart lays off 77% of workforce

February 24, 2012 by MassDevice staff

World Heart Corp. slashes 77% of its workforce across all departments, including its chief technology officer, aiming to save cash while it explores "various corporate strategic options."

World Heart Corp.

World Heart Corp. (NSDQ:WHRT) said it laid off 77% of its workforce in an effort to hoard cash while it explores "various corporate strategic options."

The Salt Lake City-based heart pump maker said the layoffs of 19 full-time workers and 1 part-time employee include its chief technology officer, John Woodard, effective today, according to a regulatory filing. Employees were notified yesterday, according to the filing.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HeartWare gains on Wall Street as losses widen in 2011 | Earnings Roundup

February 16, 2012 by MassDevice staff

HeartWare International reports widened losses but record sales for the 4th quarter.; also, Dentsply's sales rise, profits slide; DJO Global's sales, losses rise; Drägerwerk's Q4, 2011 sales, earnings drop; Spectranetics swings to Q4 red; and Q2 profits plunge for Unilens.

HeartWare logo

HeartWare International (NSDQ:HTWR) reported strong sales growth amid widening losses for the 4th quarter and 2011, and Wall Street showed some love.

The Framingham, Mass.-based heart pump maker raked in $82.8 million for the year ended Dec. 31, 2011, a 50% bump from $55.2 million in 2010. Losses, however, widened to $55.1 million, or $3.94 per diluted share. Analysts had forecast a loss of $3.17 per diluted share for 2011.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

HeartWare gains on Wall Street as losses widen in 2011

February 16, 2012 by MassDevice staff

HeartWare International reports widened losses but record sales for the 4th quarter.

HeartWare logo

HeartWare International (NSDQ:HTWR) reported strong sales growth amid widening losses for the 4th quarter and 2011, and Wall Street showed some love.

The Framingham, Mass.-based heart pump maker raked in $82.8 million for the year ended Dec. 31, 2011, a 50% bump from $55.2 million in 2010. Losses, however, widened to $55.1 million, or $3.94 per diluted share. Analysts had forecast a loss of $3.17 per diluted share for 2011.

Thoratec soars after killing it in Q3 | Earnings Roundup

February 9, 2012 by MassDevice staff

Thoratec shares gain big today after the heart pump maker reports more than 46% profit growth for the 4th quarter, lifting full-year earnings growth above 34%; also, Accuray soars on Q2 results; Hanger's Q4, 2011 profits soar; Cerner posts double-digit increases for Q4, 2011; Steris posts solid Q3 growth; Misonix swings to Q2 black; Q2 losses double for Cardiovascular Systems; Q2 sales slump, losses gape for pSivida; and DermaGraft sales trickle in for Shire.

Thoratec

Thoratec (NSDQ:THOR) shares are up more than 11% today after the heart pump maker put mid-double-digit profit growth numbers on the board for the 4th quarter and full-year 2011.

The Pleasanton, Calif.-based cardiac assist device maker logged profits of $15.3 million, or 25 cents per diluted share, on sales of $109.4 million for the 3 months ended Dec. 31, 2011. That's a 46.4% bottom-line gain and a top-line boost of 12.1%, compared with profits of $10.5 million, or 17 cents diluted EPS, on sales of $97.6 million during Q4 2010.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp